SpringWorks Therapeutics Profit Margin 2019-2022 | SWTX
Current and historical gross margin, operating margin and net profit margin for SpringWorks Therapeutics (SWTX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. SpringWorks Therapeutics net profit margin as of March 31, 2022 is 0%.
| SpringWorks Therapeutics Annual Profit Margins |
| SpringWorks Therapeutics Quarterly Profit Margins |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$1.614B |
$0.035B |
|
SpringWorks Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on developing life-changing medicines for patients with severe rare diseases and cancer. The company's product pipeline consists of Nirogacestat and Mirdametinib which are in clinical stage. SpringWorks Therapeutics Inc. is based in Stamford, United States.
|
